Back to Journals » Drug Design, Development and Therapy
Drug Design, Development and Therapy
- View all (5535)
- Volume 20, 2026 (304)
- Volume 19, 2025 (762)
- Volume 18, 2024 (430)
- Volume 17, 2023 (283)
- Volume 16, 2022 (316)
- Volume 15, 2021 (399)
- Volume 14, 2020 (477)
- Volume 13, 2019 (387)
- Volume 12, 2018 (382)
- Volume 11, 2017 (330)
- Volume 10, 2016 (374)
- Volume 9, 2015 (543)
- Volume 8, 2014 (231)
- Volume 7, 2013 (143)
- Volume 6, 2012 (42)
- Volume 5, 2011 (40)
- Volume 4, 2010 (35)
- Volume 3, 2009 (27)
- Volume 2, 2008 (29)
- Volume 1, 2007 (1)
Journal Articles:
- Modern Computational Approaches for Drug Design and Discovery (3)
- Advances in p53 Drug Discovery (4)
- Nanotechnology in Drug Delivery for Neurodegenerative Diseases (2)
- New Trends in Formulations for Oral Inhalation (1)
- Exploring Fragment-Based Approaches in Drug Discovery (2)
- Advances in design and development of ophthalmic drugs (9)
- Using Innovative Drug Delivery Systems to Improve the Efficacy and Applicability of Poorly Water-soluble Drugs (4)
- Beyond Brain Boundaries: Overcoming the Blood-Brain Barrier to Reach the Central Nervous System (1)
- A cross-sectional survey on heart failure from China: disease burden and management (3)
- Ten Years of Biosimilars in Europe (4)
Structure-Based Virtual Screening of New Skp1 Inhibitor Chemotypes Targeting F-Box Binding Interface
Hussain M, Lu Y, Wang GZ, Tariq M, Zhang J, Zhou GB, Liu J
Drug Design, Development and Therapy 2026, 20:578211
Published Date: 30 March 2026
Therapeutic Potential of Cannabinoids in Attenuating Amiodarone-Induced Pulmonary Fibrosis: An in vivo Experimental Study in Wistar Rats
Almalki RS
Drug Design, Development and Therapy 2026, 20:570825
Published Date: 4 March 2026
Drug Polymer Nanoparticles: An Advancement in Biomedical Solutions and Targeted Drug Delivery
Rananaware P, Narayan M, Brahmkhatri V
Drug Design, Development and Therapy 2026, 20:562785
Published Date: 23 February 2026
Therapeutic Efficacy of Curcumin Nanoparticles in Parkinson’s Disease: An Integrated Analysis of Network Pharmacology, Experimental Validation, and Gut Microbiota
Mu R, Liu T, Zhang Y, Xiu K, Guo X, Xia W
Drug Design, Development and Therapy 2026, 20:566113
Published Date: 22 January 2026
The Effects of Obesity on Lung Physiology, the Prevalence and Severity of Chronic Pulmonary Diseases, and Inhalation Treatment
Fröhlich E
Drug Design, Development and Therapy 2025, 19:11885-11900
Published Date: 30 December 2025
Fragment Based Drug Discovery by Microscale Thermophoresis Targeting Klebsiella pneumoniae and Escherichia coli IspE
Walsh DJ, Willocx D, Hamid R, Hamed MM, Hirsch AKH
Drug Design, Development and Therapy 2025, 19:11345-11353
Published Date: 18 December 2025
Detailed in silico Evaluation of WNV Proteins: Dynamic and Thermodynamic Insights into Doravirine as a Potential Multitarget Agent
Curcio A, Torti C, Quiros-Roldan E, Alcaro S, Artese A
Drug Design, Development and Therapy 2025, 19:11021-11043
Published Date: 12 December 2025
Benchmarking the Structure-Based Virtual Screening Performance of Wild-Type and Resistant PfDHFR Using Docking and Machine Learning Re-Scoring
Hany MS, Ahmed NS, Boeckler FM, Ibrahim TM
Drug Design, Development and Therapy 2025, 19:7045-7058
Published Date: 15 August 2025
SNAr Reactive Pyrazine Derivatives as p53-Y220C Cleft Binders with Diverse Binding Modes
Klett T, Stahlecker J, Schwer M, Jaag SJ, Masberg B, Knappe C, Lämmerhofer M, Stehle T, Boeckler FM
Drug Design, Development and Therapy 2025, 19:4727-4753
Published Date: 3 June 2025
Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
Chatzimichail E, Christodoulaki E, Konstas PAG, Tsiropoulos GN, Amaxilati E, Gugleta K, Gatzioufas Z, Panos GD
Drug Design, Development and Therapy 2025, 19:2519-2531
Published Date: 2 April 2025
Screening of Covalent Kinase Inhibitors Yields Hits for Cysteine Protease USP7 / HAUSP
Ernst LN, Jaag SJ, Wydra VR, Masberg B, Knappe C, Gerstenecker S, Serafim RAM, Liang XJ, Seidler NJ, Lämmerhofer M, Gehringer M, Boeckler FM
Drug Design, Development and Therapy 2025, 19:2253-2284
Published Date: 25 March 2025
Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation
Vagiakis I, Papadopoulou EP, Amaxilati E, Tsiropoulos GN, Konstas AG, Panos GD
Drug Design, Development and Therapy 2025, 19:703-714
Published Date: 31 January 2025
Effects of Dexamethasone Intravitreal Implant on Multifocal Electroretinography in Diabetic Macular Oedema
Tranos P, Koukoula S, de Politis PB, Tranou M, Giamouridou O, Stavrakas P, Panos GD
Drug Design, Development and Therapy 2024, 18:5367-5375
Published Date: 25 November 2024
Optimizing Pharmacological and Immunological Properties of Therapeutic Proteins Through PEGylation: Investigating Key Parameters and Their Impact
Gonçalves J, Caliceti P
Drug Design, Development and Therapy 2024, 18:5041-5062
Published Date: 7 November 2024
Novel Strategies Enhancing Bioavailability and Therapeutical Potential of Silibinin for Treatment of Liver Disorders
Selc M, Macova R, Babelova A
Drug Design, Development and Therapy 2024, 18:4629-4659
Published Date: 19 October 2024
Copolymerized Polymers Based on Cyclodextrins and Cationic Groups Enhance Therapeutic Effect of Rebamipide in the N-Acetylcysteine-Treated Dry Eye Model
Otake H, Kobayashi K, Kadowaki R, Kosaka T, Itahashi M, Tsubaki M, Matsuda M, Iwakiri N, Harata E, Nagai N
Drug Design, Development and Therapy 2024, 18:4345-4358
Published Date: 27 September 2024
Revisiting Niclosamide Formulation Approaches – a Pathway Toward Drug Repositioning
Jug M, Laffleur F, Millotti G
Drug Design, Development and Therapy 2024, 18:4153-4182
Published Date: 17 September 2024
Evaluation of a Covalent Library of Diverse Warheads (CovLib) Binding to JNK3, USP7, or p53
Klett T, Schwer M, Ernst LN, Engelhardt MU, Jaag SJ, Masberg B, Knappe C, Lämmerhofer M, Gehringer M, Boeckler FM
Drug Design, Development and Therapy 2024, 18:2653-2679
Published Date: 1 July 2024
Development and Characterization of a Novel Carbon-11 Labeled Positron Emission Tomography Radiotracer for Neuroimaging of Sirtuin 1 with Benzoxazine-Based Compounds
Wang Y, Liu Y, Wang Y, Bai P, Hallisey MR, Varela BL, Siewko A, Wang C, Xu Y
Drug Design, Development and Therapy 2024, 18:819-827
Published Date: 15 March 2024
A Window for Enhanced Oral Delivery of Therapeutics via Lipid Nanoparticles
Amekyeh H, Sabra R, Billa N
Drug Design, Development and Therapy 2024, 18:613-630
Published Date: 29 February 2024
Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?
Chatzimichail E, Pfau K, Gatzioufas Z, Panos GD
Drug Design, Development and Therapy 2024, 18:365-374
Published Date: 8 February 2024
The Role of Rho Kinase Inhibitors in Corneal Diseases
Futterknecht S, Chatzimichail E, Gugleta K, Panos GD, Gatzioufas Z
Drug Design, Development and Therapy 2024, 18:97-108
Published Date: 19 January 2024
Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies
Panos GD, Lakshmanan A, Dadoukis P, Ripa M, Motta L, Amoaku WM
Drug Design, Development and Therapy 2023, 17:2861-2873
Published Date: 18 September 2023
Synthesis of Amino Acids Bearing Halodifluoromethyl Moieties and Their Application to p53-Derived Peptides Binding to Mdm2/Mdm4
Vaas S, Zimmermann MO, Klett T, Boeckler FM
Drug Design, Development and Therapy 2023, 17:1247-1274
Published Date: 25 April 2023
Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies
Mushtaq Y, Mushtaq MM, Gatzioufas Z, Ripa M, Motta L, Panos GD
Drug Design, Development and Therapy 2023, 17:961-975
Published Date: 30 March 2023
Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies
Karasavvidou EM, Tranos P, Panos GD
Drug Design, Development and Therapy 2022, 16:2659-2680
Published Date: 9 August 2022
Care pathways and treatment patterns for patients with heart failure in China: results from a cross-sectional survey
Jackson JDS, Cotton SE, Bruce Wirta S, Proenca CC, Zhang M, Lahoz R, Balas B, Calado FJ
Drug Design, Development and Therapy 2018, 12:2311-2321
Published Date: 26 July 2018
Burden of heart failure on caregivers in China: results from a cross-sectional survey
Jackson JDS, Cotton SE, Bruce Wirta S, Proenca CC, Zhang M, Lahoz R, Calado FJ
Drug Design, Development and Therapy 2018, 12:1669-1678
Published Date: 8 June 2018
Burden of heart failure on patients from China: results from a cross-sectional survey
Jackson JDS, Cotton SE, Bruce Wirta S, Proenca CC, Zhang M, Lahoz R, Calado FJ
Drug Design, Development and Therapy 2018, 12:1659-1668
Published Date: 8 June 2018
Ten years of biosimilar recombinant human growth hormone in Europe
Saenger P
Drug Design, Development and Therapy 2017, 11:1505-1507
Published Date: 16 May 2017
Ten years of clinical experience with biosimilar human growth hormone: a review of safety data
Borrás Pérez MV, Kriström B, Romer T, Walczak M, Höbel N, Zabransky M
Drug Design, Development and Therapy 2017, 11:1497-1503
Published Date: 16 May 2017
Ten years' clinical experience with biosimilar human growth hormone: a review of efficacy data
López-Siguero JP, Pfäffle R, Chanson P, Szalecki M, Höbel N, Zabransky M
Drug Design, Development and Therapy 2017, 11:1489-1495
Published Date: 16 May 2017
Ten years of biosimilars in Europe: development and evolution of the regulatory pathways
Schiestl M, Zabransky M, Sörgel F
Drug Design, Development and Therapy 2017, 11:1509-1515
Published Date: 16 May 2017